pCMV5 TBRI-His Citations (11)
Originally described in: Joan Massague lab plasmidsUnpublished
Articles Citing pCMV5 TBRI-His
| Articles |
|---|
| The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-beta signaling. Nyati S, Schinske-Sebolt K, Pitchiaya S, Chekhovskiy K, Chator A, Chaudhry N, Dosch J, Van Dort ME, Varambally S, Kumar-Sinha C, Nyati MK, Ray D, Walter NG, Yu H, Ross BD, Rehemtulla A. Sci Signal. 2015 Jan 6;8(358):ra1. doi: 10.1126/scisignal.2005379. PubMed |
| TGFbeta1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer. Park BV, Freeman ZT, Ghasemzadeh A, Chattergoon MA, Rutebemberwa A, Steigner J, Winter ME, Huynh TV, Sebald SM, Lee SJ, Pan F, Pardoll DM, Cox AL. Cancer Discov. 2016 Dec;6(12):1366-1381. Epub 2016 Sep 28. PubMed |
| A Requirement for ZAK Kinase Activity in Canonical TGF-beta Signaling. Nyati S, Chator A, Schinske K, Gregg BS, Ross BD, Rehemtulla A. Transl Oncol. 2016 Dec;9(6):473-481. doi: 10.1016/j.tranon.2016.09.010. Epub 2016 Oct 23. PubMed |
| Sterol Regulatory Element Binding Protein (SREBP)-1 is a novel regulator of the Transforming Growth Factor (TGF)-beta receptor I (TbetaRI) through exosomal secretion. Van Krieken R, Chen G, Gao B, Read J, Al Saleh HA, Li R, Al-Nedawi K, Krepinsky JC. Cell Signal. 2017 Jan;29:158-167. doi: 10.1016/j.cellsig.2016.11.004. Epub 2016 Nov 5. PubMed |
| PAR1 Scaffolds TGFbetaRII to Downregulate TGF-beta Signaling and Activate ESC Differentiation to Endothelial Cells. Gong H, An S, Sassmann A, Liu M, Mastej V, Mittal M, Zhang W, Hong Z, Offermanns S, Rehman J, Malik AB. Stem Cell Reports. 2016 Dec 13;7(6):1050-1058. doi: 10.1016/j.stemcr.2016.10.006. Epub 2016 Nov 17. PubMed |
| Binding of coronin 1B to TbetaRI negatively regulates the TGFbeta1 signaling pathway. Kim GY, Lim HJ, Park HY. Biochem Biophys Res Commun. 2017 Aug 19;490(2):574-579. doi: 10.1016/j.bbrc.2017.06.080. Epub 2017 Jun 15. PubMed |
| TGF-beta receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. Gencer S, Oleinik N, Kim J, Panneer Selvam S, De Palma R, Dany M, Nganga R, Thomas RJ, Senkal CE, Howe PH, Ogretmen B. Sci Signal. 2017 Oct 24;10(502). pii: 10/502/eaam7464. doi: 10.1126/scisignal.aam7464. PubMed |
| Interleukin-6-mediated trans-signaling inhibits transforming growth factor-beta signaling in trabecular meshwork cells. Inoue-Mochita M, Inoue T, Kojima S, Futakuchi A, Fujimoto T, Sato-Ohira S, Tsutsumi U, Tanihara H. J Biol Chem. 2018 Jul 13;293(28):10975-10984. doi: 10.1074/jbc.RA118.003298. Epub 2018 May 11. PubMed |
| Protein kinase CK2 activation is required for transforming growth factor beta-induced epithelial-mesenchymal transition. Kim S, Ham S, Yang K, Kim K. Mol Oncol. 2018 Oct;12(10):1811-1826. doi: 10.1002/1878-0261.12378. Epub 2018 Sep 21. PubMed |
| The involvement of lipid raft pathway in suppression of TGFbeta-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells. Sun J, Tao R, Mao T, Feng Z, Guo Q, Zhang X. Toxicol Appl Pharmacol. 2019 Oct 1;380:114696. doi: 10.1016/j.taap.2019.114696. Epub 2019 Aug 2. PubMed |
| TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-beta signaling. Nyati S, Gregg BS, Xu J, Young G, Kimmel L, Nyati MK, Ray D, Speers C, Rehemtulla A. Neoplasia. 2020 Apr;22(4):163-178. doi: 10.1016/j.neo.2020.02.001. Epub 2020 Mar 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.